Search

everythinglearnresearchcommunity

for

Search:↓

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

People with alopecia areata have a higher risk of heart disease.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Removing the thymoma improved the patient's alopecia areata, suggesting a possible link between the two.

Current treatments for alopecia areata can help hair grow but don't cure the disease.

Erianin may effectively treat alopecia areata by targeting the immune system.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Alopecia areata might help slow down certain cancers.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

A lower second to fourth finger length ratio may predict male alopecia areata.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

These gene variations are not linked to alopecia areata in Egyptians.

Treating gum disease and stress may help improve alopecia.

Upadacitinib may effectively treat alopecia areata without side effects.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

The study suggests that hypothyroidism may cause alopecia areata.

Cinnamaldehyde helps bone healing initially but may slow healing later unless combined with DHT treatment.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Early and proper treatment is crucial for children with allergic conjunctivitis to avoid complications.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

There's no link between low iron levels and the hair loss condition, alopecia areata.

Stress-related hair loss was reversed with a special medication.